Envestnet Portfolio Solutions
IDXX icon

Envestnet Portfolio Solutions’s Idexx Laboratories IDXX Stock Holding History

Envestnet Portfolio Solutions’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.3M Buy
28,991
+761
+3% +$427K 0.07% 166
2026
Q1 		$15.9M Sell
28,230
-2,445
-8% -$1.57M 0.09% 135
2025
Q4 		$20.8M Buy
30,675
+9,580
+45% +$6.52M 0.07% 135
2025
Q3 		$13.5M Sell
21,095
-1,349
-6% -$819K 0.05% 192
2025
Q2 		$12M Buy
22,444
+5,795
+35% +$2.77M 0.04% 200
2025
Q1 		$6.99M Sell
16,649
-1,875
-10% -$814K 0.03% 290
2024
Q4 		$7.66M Sell
18,524
-60
-0.3% -$26.3K 0.03% 305
2024
Q3 		$9.39M Sell
18,584
-1,783
-9% -$866K 0.03% 255
2024
Q2 		$9.92M Sell
20,367
-468
-2% -$235K 0.03% 234
2024
Q1 		$11.2M Buy
20,835
+6,249
+43% +$3.42M 0.04% 208
2023
Q4 		$8.1M Buy
14,586
+434
+3% +$204K 0.03% 234
2023
Q3 		$6.19M Buy
+14,152
New +$7.06M 0.03% 261

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Envestnet Portfolio Solutions's IDXX Position: Q2 2026 in Review

Envestnet Portfolio Solutions increased its Idexx Laboratories (IDXX) stake by 2.7% in Q2 2026, buying an estimated $427K and bringing the position to 28,991 shares worth $15.3M. The position accounts for 0.07% of the portfolio, ranked #166.

Envestnet Portfolio Solutions first reported a position in IDXX in Q3 2023 and has held it in 12 quarters since. The position peaked at $20.8M in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Envestnet Portfolio Solutions held 28,991 shares of Idexx Laboratories worth $15.3M as of Q2 2026.
  • Envestnet Portfolio Solutions bought 761 Idexx Laboratories shares in Q2 2026, an estimated $427K.
  • Idexx Laboratories made up 0.07% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #166 holding.
  • Envestnet Portfolio Solutions first reported a position in Idexx Laboratories in Q3 2023 and has held it in 12 quarters since.
  • Envestnet Portfolio Solutions's Idexx Laboratories position peaked at $20.8M in Q4 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.